Selective vasoactive intestinal peptide (VIP) receptor antagonist (IC50
= 125.8 nM). Displays no activity on glucagon, secretin or GRF receptors.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6,Leu17]VIP.
Pandol et al.
Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
Pozo et al.
Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie et al.
The citations listed below are publications that use Tocris products. Selected citations for [D-p-Cl-Phe6,Leu17]-VIP include:
Showing Results 1 - 4 of 4